Exploring vimentin expression and its protein interactors across diverse cancer types via the cancer genome atlas datasets: a comprehensive analysis

  • 0Department of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland.

Summary

This summary is machine-generated.

Vimentin (VIM) is overexpressed in multiple cancers and linked to promoter methylation. This suggests VIM

Area Of Science

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background

  • The global cancer burden is increasing, with late-stage diagnosis hindering effective treatment.
  • Vimentin (VIM) shows promise as a biomarker for cancer diagnosis and prognosis.
  • Early cancer detection remains a critical challenge in improving patient survival rates.

Purpose Of The Study

  • To investigate Vimentin (VIM) expression and promoter methylation across diverse cancer types.
  • To analyze Vimentin's protein-protein interactions and mutation frequencies using bioinformatics.
  • To explore the potential of Vimentin as a diagnostic and therapeutic target in oncology.

Main Methods

  • Utilized The Cancer Genome Atlas (TCGA) datasets for gene expression and methylation analysis.
  • Employed advanced bioinformatics tools to study protein-protein interactions and mutation data.
  • Focused on Vimentin (VIM) as the central biomarker in the investigation.

Main Results

  • Vimentin (VIM) was found to be overexpressed in seven distinct cancer types, including breast invasive carcinoma and glioblastoma.
  • A correlation between VIM expression and promoter methylation was observed in specific cancer types.
  • Identified complex protein interactions involving VIM, implicating it in proliferation and apoptosis pathways.

Conclusions

  • Vimentin (VIM) plays a significant role in cancer development and progression.
  • VIM's involvement in key cellular processes highlights its potential as a therapeutic target.
  • These findings support Vimentin's utility as a diagnostic marker for various cancers.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes 01:05

7.2K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

mTOR Signaling and Cancer Progression 03:03

3.6K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer-Critical Genes I: Proto-oncogenes 01:33

8.5K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Tumor Progression 02:07

6.1K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Protein Networks 02:26

3.9K

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

Cancers Originate from Somatic Mutations in a Single Cell 02:21

11.3K

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...